Ja. Yergey et al., In vitro metabolism of the Cox-2 inhibitor DFU, including a novel glutathione adduct rearomatization, DRUG META D, 29(5), 2001, pp. 638-644
The metabolic profile of DFU [5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsu
lphonyl)phenyl-2(5H)-furanone], a potent and selective COX-2 inhibitor, was
characterized using in vitro microsomal and hepatocyte incubations. A sing
le product, corresponding to p-hydroxylation, p-OH-DFU [(5,5-dimethyl-3-(3-
fluoro-4-hydroxyphenyl)-4-(4-methylsulphonyl)phenyl-2(5H)- furanone)], was
produced in rat microsomal incubations of DFU. In contrast, three metabolit
es were produced in incubations using suspensions of freshly isolated rat h
epatocytes. Microsomal production of the p-O-glucuronide metabolite of DFU
from synthetic p-OH-DFU was shown to have chromatographic and mass spectrom
etric properties identical to the earliest eluting hepatocyte metabolite (M
1). The molecular weights of the other two hepatocyte metabolites were read
ily obtained using capillary high-performance liquid chromatography continu
ous-flow liquid secondary ion mass spectrometry (HPLC/CF-LSIMS); however, t
he elemental composition of these metabolites was not. Unlike typical metab
olic products, which produce readily identified increments in molecular wei
ght, metabolites M2 and M3 produced molecular ions in positive- and negativ
e-ion CF-LSIMS that were consistent with oxidation of DFU (+16 Da), followe
d by addition of glutathione (+306 Da) and subsequent loss of 20 and 18 Da,
respectively. Capillary HPLC/high-resolution CF-LSIMS was used to generate
accurate mass data for M2 and M3 that provided evidence that the losses of
20 and 18 Da, respectively, corresponded to a rearomatization through loss
of HF or H2O. Isolation and NMR characterization provided the definitive s
tructural proof for these metabolites. Overall, the metabolism of DFU in ra
t hepatocytes is proposed to proceed through an epoxide intermediate, which
then either rearranges to the p-OH-DFU and is conjugated with glucuronic a
cid, or is trapped with glutathione, followed by rearomatization with loss
of HF (M2) or H2O (M3).